Trading Halt

Jul 30, 2026 at 7:22 PM EDT · Issued by Neurotech International Ltd. via ASX

Filed with ASX · Jul 30, 2026 at 7:22 PM EDT

On 6ix: 6ix.com/news/trading-halt-2018

Market Announcement 31 July 2026 31 July 2026 Market Announcement 1/1 ASX Limited ASX Customer Service Centre 131 279 | asx.com.au Neurotech International Limited (ASX: NTI) – Trading Halt Trading in the securities of Neurotech International Limited (‘NTI’) will be...

View Attachment

6ix hasn’t read this filing yet.

Neurotech International Ltd. on 6ix

Earlier from Neurotech International

NTI164 Phase II/III Autism Data Accepted for PublicationJul 29
Neurotech secures $3.15 million R&D tax incentive loanJul 14
US FDA clears IND for NTI164Jul 13
NTI secures Notices of Allowance for US patent applicationsJul 1
NTI initiates First Clinical Site for Phase 3 ASD TrialMar 16

Later from Neurotech International

Quarterly Activities/Appendix 4C Cash Flow ReportJul 30
Proposed issue of securities - NTIAug 3
Receipt of Binding Commitments for $4.5m PlacementAug 3
Application for quotation of securities - NTIAug 11
Secondary Trading NoticeAug 11

All Neurotech International news releases

Follow Neurotech International into a list and get an email when it puts out news.

Follow Neurotech International